CardioGenics Holdings (CardioGenics Holdings) Interest Coverage : 0 (At Loss) (As of Jan. 2016)

CardioGenics Holdings Interest Coverage Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
Interest Coverage		Get a 7-Day Free Trial					-	-	-	-	-

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Interest Coverage	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CardioGenics Holdings's Interest Coverage

For the Diagnostics & Research subindustry, CardioGenics Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Interest Coverage Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Interest Coverage distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Interest Coverage falls into.

CardioGenics Holdings Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Else if Interest Expense is negative and Operating Income is negative, then

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CardioGenics Holdings's Interest Coverage for the fiscal year that ended in Oct. 2015 is calculated as

Here, for the fiscal year that ended in Oct. 2015, CardioGenics Holdings's Interest Expense was $-0.48 Mil. Its Operating Income was $-0.77 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

CardioGenics Holdings's Interest Coverage for the quarter that ended in Jan. 2016 is calculated as

Here, for the three months ended in Jan. 2016, CardioGenics Holdings's Interest Expense was $-0.13 Mil. Its Operating Income was $-0.20 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

CardioGenics Holdings  (OTCPK:CGNH) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

CardioGenics Holdings Interest Coverage Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description